[NMusers] PhD candidate position M&S Neglected Tropical Diseases

From: <t.dorlo_at_nki.nl>
Date: Wed, 9 May 2018 15:04:59 +0000

We are searching for a PhD candidate for an exciting and high-impact resear=
ch project on the topic of modelling and simulation of pharmacokinetics (PK=
) and pharmacodynamics (PD) of new drugs and drug combinations against the =
neglected tropical disease visceral leishmaniasis. The activities will enta=
il pharmacometric modelling of PK and PD data to support an ongoing phase I=
I/III clinical trial and to prepare for future clinical trials, amongst oth=
ers in Eastern Africa and South Asia.

The research will be executed within the Pharmacometrics group of the Pharm=
acy of the Antoni van Leeuwenhoek hospital - Netherlands Cancer Institute i=
n Amsterdam, the Netherlands, and will be performed in close collaboration =
with the non-profit organization Drugs for Neglected Diseases initiative (D=

For further details, please see: https://www.nki.nl/working-at-the-nki/phd-=
candidate-pharmacometricsclinical-pharmacology/ or contact dr. T.P.C. Dorlo=
, tel. +31 20 512 4741 or e-mail: t.dorlo_at_nki.nl<mailto:t.dorlo_at_nki.nl>.

If you are interested, please submit your application including CV and moti=
vational letter through our website: https://www.nki.nl/working-at-the-nki/=

Best wishes,


Thomas P.C. Dorlo, PhD
Pharmacometrician, senior researcher
Dept. Pharmacy & Pharmacology

Google Scholar<https://scholar.google.nl/citations?user=y3J9YwIAAAAJ&hl=
=en> | ResearchGate<https://www.researchgate.net/profile/Thomas_Dorlo> | =

t: +31 20 512 4741
e: t.dorlo_at_nki.nl


Antoni van Leeuwenhoek | Plesmanlaan 121 | 1066 CX AMSTERDAM | www.avl.nl<h=

Dit e-mailbericht is uitsluitend bestemd voor de geadresseerde(n). Als dit =
bericht niet voor u bestemd is, wordt u vriendelijk verzocht dit aan de afz=
ender te melden. Het Antoni van Leeuwenhoek (AVL) staat door de elektronisc=
he verzending van dit bericht niet in voor de juiste en volledige overbreng=
ing van de inhoud, noch voor tijdige ontvangst daarvan. Voor informatie ove=
r het AVL raadpleegt u www.avl.nl<http://www.avl.nl/>.

This e-mail is intended for the addressee(s) eyes only. If you are not the =
intended recipient, you are hereby kindly requested to inform the sender of=
 this. In view of the electronic nature of this communication, The Netherla=
nds Cancer Institute (NKI) is neither liable for the proper and complete tr=
ansmission of the information contained therein nor for any delay in its re=
ceipt. For information about the Netherlands Cancer Institute, go to www.nk=

(image/jpeg attachment: image001.jpg)

Received on Wed May 09 2018 - 11:04:59 EDT

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 16:59:35 EDT